Title : Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.

Pub. Date : 2007 Oct 1

PMID : 17622571






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Atorvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
2 Atorvastatin"s effects on MYC were specific to the inhibition of HMGcoA reductase, as treatment with mevalonate, the product of HMG-CoA reductase activity, abrogated these effects and inhibited the ability of atorvastatin to reverse or suppress tumorigenesis. Atorvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
3 Atorvastatin"s effects on MYC were specific to the inhibition of HMGcoA reductase, as treatment with mevalonate, the product of HMG-CoA reductase activity, abrogated these effects and inhibited the ability of atorvastatin to reverse or suppress tumorigenesis. Atorvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
4 Thus, atorvastatin, by inhibiting HMGcoA reductase, induces changes in phosphoprotein signaling that in turn prevent MYC-induced lymphomagenesis. Atorvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens